Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mereo Biopharma Group Plc

2.05
+0.05002.50%
Post-market: 2.050.00000.00%19:46 EDT
Volume:1.47M
Turnover:2.95M
Market Cap:326.15M
PE:-6.48
High:2.06
Open:2.00
Low:1.94
Close:2.00
52wk High:4.72
52wk Low:1.47
Shares:159.10M
Float Shares:100.47M
Volume Ratio:1.51
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3162
EPS(LYR):-0.2924
ROE:-74.61%
ROA:-35.13%
PB:6.02
PE(LYR):-7.01

Loading ...

Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jul 10, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2025

Major Issues Report

Form 8-K - Current report
Jan 23, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities